tetano
Editor, Senior Moderator
Semin Fetal Neonatal Med
. 2023 Mar 30;101431.
doi: 10.1016/j.siny.2023.101431. Online ahead of print.
Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19
Viraraghavan Vadakkencherry Ramaswamy[SUP] 1 [/SUP], Thangaraj Abiramalatha[SUP] 2 [/SUP], Abdul Kareem Pullattayil S[SUP] 3 [/SUP], Daniele Trevisanuto[SUP] 4 [/SUP]
Affiliations
Abstract
Multisystem inflammatory disease in neonates (MIS-N) is a disease of immune dysregulation presenting in the newborn period. Thouvgh its etiopathogenesis is proposed to be similar to multisystem inflammatory disease in Children (MIS-C), the exact pathophysiology is largely unknown as of present. The definition of MIS-N is contentious. The evidence for its incidence, the clinical features, profile of raised inflammatory markers, treatment strategies and outcomes stem from case reports, case series and cohort studies with small sample sizes. Though the incidence of MIS-N in severe acute respiratory syndrome caused by the coronavirus CoVID-2 (SARS-CoV-2) infected asymptomatic neonates is low, its incidence in symptomatic neonates is relatively higher. Further, amongst the neonates who are treated as MIS-N, the mortality rate is high. The review also evaluates the various other unresolved aspects of MIS-N from limited published literature and identifies knowledge gaps which could be areas of future research.
. 2023 Mar 30;101431.
doi: 10.1016/j.siny.2023.101431. Online ahead of print.
Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19
Viraraghavan Vadakkencherry Ramaswamy[SUP] 1 [/SUP], Thangaraj Abiramalatha[SUP] 2 [/SUP], Abdul Kareem Pullattayil S[SUP] 3 [/SUP], Daniele Trevisanuto[SUP] 4 [/SUP]
Affiliations
- PMID: 37061425
- DOI: 10.1016/j.siny.2023.101431
Abstract
Multisystem inflammatory disease in neonates (MIS-N) is a disease of immune dysregulation presenting in the newborn period. Thouvgh its etiopathogenesis is proposed to be similar to multisystem inflammatory disease in Children (MIS-C), the exact pathophysiology is largely unknown as of present. The definition of MIS-N is contentious. The evidence for its incidence, the clinical features, profile of raised inflammatory markers, treatment strategies and outcomes stem from case reports, case series and cohort studies with small sample sizes. Though the incidence of MIS-N in severe acute respiratory syndrome caused by the coronavirus CoVID-2 (SARS-CoV-2) infected asymptomatic neonates is low, its incidence in symptomatic neonates is relatively higher. Further, amongst the neonates who are treated as MIS-N, the mortality rate is high. The review also evaluates the various other unresolved aspects of MIS-N from limited published literature and identifies knowledge gaps which could be areas of future research.